What the implications of a new census could be

By Steve Inskeep

Published August 8, 2025 at 4:17 AM EDT

NPR's Steve Inskeep talks with John Bisognano, president of the National Democratic Redistricting Committee, about efforts to remap congressional districts, and what President Trump's proposed new census could mean.

Steve Inskeep

Steve Inskeep is a host of NPR's Morning Edition, as well as NPR's morning news podcast Up First.

See stories by Steve Inskeep

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

NPR News

A word is born -- and critiqued: 'healthocide'

Ari Daniel

This week a new word made its public debut. With an increase in attacks on health care facilities and personnel, the goal of this coinage is to spark outrage and outcry. But the reaction is mixed.
NPR News

Israel plans to take control of Gaza City. And, Trump wants a new U.S. census

Brittney Melton

Israel has announced plans to extend the Gaza war and take over Gaza City. And, President Trump wants a new U.S. census to exclude people without legal status.
NPR News

Hundreds of children disappeared in Argentina. Their grandmothers united to find them

Ericka Taylor

Haley Cohen Gilliland's A Flower Traveled in My Blood tells the story of a group of grandmothers who spent decades searching for their stolen grandchildren during and after Argentina's "Dirty War."
NPR News

Teen heartthrobs named Bobby were everywhere in the '60s — which was fine by me

Bob Mondello

Bobbys were inescapable in music in the '50s and '60s: Bobby Sherman, Bobby Rydell, Bobby Darin and more. NPR critic Bob Mondello looks back to an era when everyone seemed to share his name.
The Commonwealth

Central Kentucky health officials say they're concerned about Kennedy's mRNA contract cancellations

John McGary

Health and Human Services Secretary and long-time vaccine critic Robert F. Kennedy Junior’s decision to cancel $500 million in mRNA research contracts is being heavily criticized by health officials across the country.